焦氏头针运动区针刺治疗缺血性脑卒中患者运动功能障碍:随机对照试验研究方案
本研究为评估者与分析者设盲的随机对照试验,拟纳入108例符合纳入标准的缺血性脑卒中运动功能障碍患者,按1:1比例随机分为针刺组与对照组。对照组接受常规康复治疗,针刺组接受焦氏头针联合常规康复治疗,8周内完成40次治疗。主要结局为Fugl-Meyer评定量表,次要结局包括改良Barthel指数、卒中专用生活质量量表及卒中中医证候量表,于基线、第4周(治疗20次)、第8周(治疗40次)、第12周(随访)和第16周(随访)进行评估。
要点
- 这是首个评估焦氏头针治疗缺血性脑卒中运动功能障碍疗效与安全性的随机对照试验。
- 108例患者按1:1随机分为焦氏头针联合常规康复组与常规康复对照组。
- 主要结局为Fugl-Meyer评定量表,8周内完成40次治疗,随访至第16周。
核心结论
- 本研究为首个评估焦氏头针治疗缺血性脑卒中运动功能障碍疗效与安全性的试验,结果预期提供焦氏头针可作为改善缺血性脑卒中运动功能障碍的有效康复治疗方法的证据。
研究设计与样本
- 评估者与分析者设盲的随机对照试验,拟纳入108例符合纳入标准的缺血性脑卒中运动功能障碍患者,按1:1比例随机分为针刺组与对照组。
- 对照组接受常规康复治疗,针刺组接受焦氏头针联合常规康复治疗,8周内完成40次治疗。
- 主要结局为Fugl-Meyer评定量表,次要结局为改良Barthel指数、卒中专用生活质量量表及卒中中医证候量表。
- 所有评估于基线、第4周(治疗20次)、第8周(治疗40次)、第12周(随访)和第16周(随访)进行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Scalp acupuncture has shown a remarkable treatment efficacy on motor dysfunction in patients with stroke in China, especially the motor area of Jiao's scalp acupuncture, which is the most widely used treatment. However, previous studies have summarized that the clinical curative effect of acupuncture treatment for stroke remains uncertain. Meanwhile, no randomized controlled trials on Jiao's scalp acupuncture have been performed. The aim of this study is to evaluate the efficacy and safety of Jiao's scalp acupuncture for motor dysfunction in ischemic stroke. METHODS/DESIGN: This is an assessor- and analyst-blinded, randomized controlled trial. One hundred and eight stroke patients with motor dysfunction meeting the inclusion criteria will be allocated by a 1:1 ratio into either an acupuncture treatment group or a control group. Stroke patients in the control group will receive conventional rehabilitation treatment, whereas a combination of Jiao's scalp acupuncture and conventional rehabilitation treatment will be applied to the acupuncture group. Forty treatment sessions will be performed over an 8-week period. The Fugl-Meyer Assessment scale will be assessed as the primary outcome measure. The Modified Barthel Index, the Stroke-Specific Quality of Life, and the Stroke Syndrome of Traditional Chinese Medicine scales will be selected as secondary outcome measurements. All assessments will be conducted at baseline, week 4 (treatment 20), week 8 (treatment 40), week 12 (follow-up), and week 16 (follow-up). DISCUSSION: This is the first trial evaluating the efficacy and safety of Jiao's scalp acupuncture for motor dysfunction in ischemic stroke. The results of this trial are expected to provide relevant evidence demonstrating that Jiao's scalp acupuncture can be used as an effective rehabilitation treatment method for improving motor dysfunction in ischemic stroke. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02871453 . Registered on 17 July 2016.
引用
- Wang J, Pei J, Khiati D, et al. Acupuncture treatment on the motor area of the scalp for motor dysfunction in patients with ischemic stroke: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28633675. doi:10.1186/s13063-017-2000-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。